Seeing Is Believing
Currently out of the existing stock ratings of Bruce Jackson, 131 are a BUY (88.51%), 16 are a HOLD (10.81%), 1 are a SELL (0.68%).
Analyst Bruce Jackson, currently employed at BENCHMARK, carries an average stock price target met ratio of 46.9% that have a potential upside of 35.9% achieved within 145 days.
Bruce Jackson’s has documented 267 price targets and ratings displayed on 24 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on HUMA, Humacyte at 27-Feb-2025.
Analyst best performing recommendations are on BFRI (BIOFRONTERA).
The best stock recommendation documented was for BFRI (BIOFRONTERA) at 12/16/2021. The price target of $220 was fulfilled within 5 days with a profit of $82 (59.42%) receiving and performance score of 118.84.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
3 years 7 months 10 days ago
(22-Jul-2021)
1/1 (100%)
$6.31 (110.90%)
484
Buy
$10
$9.54 (2073.91%)
$8
4 years 3 months 1 days ago
(03-Dec-2020)
0/3 (0%)
$4.16 (59.27%)
Buy
4 years 8 months 15 days ago
(17-Jun-2020)
2/2 (100%)
$1.27 (34.05%)
162
Buy
$12
$11.54 (2508.70%)
$9
4 years 10 months 16 days ago
(16-Apr-2020)
4/4 (100%)
$2.83 (60.84%)
188
Which stock is Bruce Jackson is most bullish on?
Which stock is Bruce Jackson is most reserved on?
What Year was the first public recommendation made by Bruce Jackson?